# VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

> **NCT03953768** · NA · RECRUITING · sponsor: **University of Louisville** · enrollment: 30 (estimated)

## Conditions studied

- Autoimmune Diseases
- Epilepsy
- Autonomic Dysfunction
- Inflammatory Bowel Diseases

## Interventions

- **DEVICE:** Vagal nerve stimulation (VNS)

## Key facts

- **NCT ID:** NCT03953768
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2025-12-13
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03953768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03953768, "VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03953768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*